Olba Healthcare Holdings, Inc. · TSE:2689
Olba Healthcare — FY2025 Earnings Presentation
55 slides from Olba Healthcare's earnings presentation, Oct 23, 2025
Slide 1: Financial Results Report FY 06/2025
Financial Results Report FY 06/2025 OLBA HEALTHCARE HOLDINGS, INC. (formerly KAWANISHI HOLDINGS INC.) This presentation includes machine translation. Please consider that some content may not be perfectly accurate or contextually appropriate. (Securities code: 2689)
Slide 2: Contents
Contents ◆ Corporate Philosophy ◆ Summary of FY 06/2025 ◆ FY2026 Forecast of Results and Basic Policy for Distribution ◆ Outline of the Medium-Term Management Plan ◆ Reference Materials
Slide 3: Corporate Philosophy
Corporate Philosophy oo OLBA HEALTHCARE
Slide 4: Corporate Philosophy and Significance of Presence
Corporate Philosophy and Significance of Presence (purpose) Aiming to develop medical science, medical care, and long-term nursing care through our business endeavors 4 ©OLBA HEALTHCARE HOLDINGS, Inc.
Slide 5: FY June 2025 Summary of Results
FY June 2025 Summary of Results
Slide 6: Domestic market size of medical devices
Domestic market size of medical devices Stable market growth despite policies to curb medical costs In fiscal 2024, Forecast of ¥3.794 trillion ・Recovering from the Impact of the New Corona and Stable Market Expansion ・Market expansion due to increase in number of surgeries and introduction of new p
Slide 7: Performance Topics: Market Environment
Performance Topics: Market Environment ■Global inflation and depreciation of the yen ・Prices of medical devices, many of which are overseas products, continue to trend upward ⇒ Implemented measures to expand sales activities and improve purchasing ⇒ Conducted negotiations to pass on the increase to
Slide 8: Performance Topics: Our Status
Performance Topics: Our Status ■Establishment of Kansai Branch in mainstay medical equipment business ・Acquired customers in the Kansai area and promoted Kobe Sales Office to Kansai Branch ⇒ Sales of the area's mainstay orthopedic consumables increased 10.6% year on year in total. ■Strong sales of c
Slide 9: Consolidated Financial Results for the Fiscal Year Ended June 2025
Consolidated Financial Results for the Fiscal Year Ended June 2025 Net sales reached a record high, but profits declined Comparison with Millions of yen YoY change budget Net sales 122,702 △0.8% +3.5% Gross profit 13,909 △3.7% +2.3% Gross profit margin 11.34% △0.34 △0.14 SG&A expenses 11,929 △2.0% +
Slide 10: Factors behind Changes in Operating Income FY June 2025
Factors behind Changes in Operating Income for the Fiscal Year Ended June 2025 (Millions of yen) [Major factors behind the decrease] 3,000 ・Decrease in equipment sales in the medical equipment business ・SG&A expenses increased due to continued investment in Medical equipment business human resources
Slide 11: Results by Business Segment
Results by Business Segment for the Fiscal Year Ended June 2025 Sales Mix [FY2025] Net sales (operating profit) ※Sales include inter-segment sales Medical equipment SPD Nursing care products 115.8 billion yen Medical equipment business (1.77 billion yen) Total partners in the medical field 4.6% 2.2%
Slide 12: Medical equipment business
Medical equipment business Total partners in the medical field Medical equipment [93.2%] Comparison Millions of yen Actual YoY change with budget ※1 Net sales 115,878 △0.9% +3.3% Net sales Operating Composition 1,774 △13.7% △12.9% ratio income Millions of yen Sales Results ※2 YoY change Kawanishi 77
Slide 13: Medical Equipment Business Consumables
Medical Equipment Business Consumables Sales ¥103.4 billion up 6.5% year on year Millions of yen Product Classification Net sales YoY change Points of sub-segments Increase in number of surgical procedures and steady progress in Olympus distributor activities Surgical consumables 50,457 +3.9% Medica
Slide 14: Medical Equipment Business Equipment
Medical Equipment Business Equipment Net sales ¥14.6 billion YoY 14.5% down Points of Equipment Sales ◆Increase in demand due to subsidies for new corona, etc. paused ◆Decline in willingness to invest in facilities due to deterioration in the business environment of hospitals ◆Sales of automated pay
Slide 15: SPD business
SPD business HOSNET・Japan, Inc. Medical products distribution specialist Comparison Millions of yen Actual YoY change with budget ※ Net sales 5,717 +4.0% +9.4% Goods Information Purchasing management management management Operating 113 +4.2% +9.0% income ※Net sales (including changes from budget and
Slide 16: Nursing Care Products Business
Nursing Care Products Business Life Care Co., Ltd. Total support for nursing care products Comparison Millions of yen Actual YoY change with budget ※ Net sales 2,777 +0.2% +5.2% Rental Sales Renovation Operating 205 △11.5% △1.8% income ※Net sales (including changes from budget and changes from the p
Slide 17: FY2026 Forecast and Basic Policy on Dividends
From the FY2026 results forecast Basic policy on dividends
Slide 18: Forecast of Consolidated Financial Results for FY June 2026
Forecast of Consolidated Financial Results for the Fiscal Year Ending June 2026 Net sales and gross profit are expected to reach record highs and operating income is expected to increase slightly (Millions of yen) Forecast 2025/6 Result Change Net sales 127,978 122,702 +4.3% Gross profit 14,856 13,9
Slide 19: Factors behind Changes in Operating Income FY June 2026
Factors behind Changes in Operating Income for the Fiscal Year Ended June 2026 (Millions of yen) [Major Factors of Changes] 3,000 ・Further market development in the Kansai area ・SG&A expenses increased due to continued investment in Medical equipment business human resources and systems. 2,800 239 N
Slide 20: Consolidated net sales: Record forecast
[Consolidated net sales] Record forecast FY June 2026 Forecast of ¥127.9 billion Sixth consecutive year of sales growth and record highs (+4.3% YoY) (Millions of yen) 160,000 127,978 122,702 118,564 120,000 107,959 110,472 80,000 60,627 63,302 57,466 53,030 53,718 40,000 0 Half-year Full year Half-y
Slide 21: Consolidated operating income: Forecast of a slight increase
[Consolidated operating income] Forecast of a slight increase in profits Forecast for FY6/2026: 2 billion yen Aiming to recover to the ¥2 billion level in the fiscal year under review (Up 1.0% year on year) (Millions of yen) 2,500 2,226 2,151 2,073 1,979 2,000 2,000 1,500 1,000 854 786 746 808 793 5
Slide 22: Basic policy on dividends
Basic policy on dividends ① Aiming to increase or maintain dividends ② We will endeavor to retain internal reserves for growth investments. FY6/26 forecast: JPY80 Dividend per share [Dividends for the most recent 10 years] Dividend on equity (DOE) ratio Dividend yield 5.0% 4.0% 4.5% DOE 4.0% 4.0% 80
Slide 23: Analysis of Capital Cost and Capital Profitability
Analysis of Capital Cost and Capital Profitability ROE・Cost of equity 20.0% ・Equity spread (%) 18.0% 17.8% (Cost of ROE-equity) 16.0% ⇒ Approx. 6% to 7% 13.8% 14.0% ・For the cost of capital on an ongoing basis 14.6% 12.0% 12.8% 12.1% Achieve higher profitability on capital 10.0% ・Five-year historica
Slide 24: Initiatives to Improve PBR
Initiatives to Improve PBR Net profit to sales Improve productivity by streamlining through DX, etc. (1.17%) Promoting new high-value-added businesses ROE Asset turnover Proper debt collection and inventory management (12.1%) (2.8 turns) Enhancement of shareholders' equity in line with Financial Lev
Slide 25: Outline of the Medium-Term Management Plan
Outline of the Medium-Term Management Plan
Slide 26: VISION2030 Sustainable Growth and Shareholder Returns Initiatives
VISION2030 Sustainable Growth and Shareholder Returns Initiatives VISION 2030 Top domestic trading company 20% of operating income More than 30 new products for medical devices from overseas and services [Main market] [Growth Strategy] [Shareholder Returns] Medical and nursing Expansion into new bus
Slide 27: Medium-term management plan key points
Medium-term management plan (FY June 2028: ¥142 billion in sales, ¥2.7 billion in operating profit) Key Points of the 2026/6-2028/6 Medium-Term Management Plan OLBA-DX Productivity improvement Strengthen and streamline operations Sophistication of Develop new regions and CRM/SFA/BI construction sale
Slide 28: Medium-Term Management Plan: Key Points of Initiatives
Medium-Term Management Plan: Key Points of Initiatives ➢ OLBA-DX : Utilization sales quality by streamlining operations and utilizing ICT tools Working to improve employee IT skills ➢ Improve productivity : Strengthen current operations and innovate logistics (construct new logistics center) Aiming
Slide 29: Reforming by OLBA-DX DX Promotion Office
Reforming by OLBA-DX DX Promotion Office OLBA-DX [In-house no-code tool utilization study session] Status of DX Measures ➢ Promote further sales support and operational efficiency ・Expand use of generated AI ・Expanded use of no-code tools ・CRM, SFA construction: demonstration stage ・Renewal of group
Slide 30: OLBA-DX DX Initiatives
OLBA-DX DX Initiatives OLBA-DX Began events for kintone no-code tool With an application created in-house Kintone hive 2025 held in Hiroshima in May 2025 Achieve greater operational efficiency Advocating to the Chugoku-Shikoku Convention and introducing the company's initiatives Utilizing Cybozu's k
Slide 31: Logistics innovation
Logistics innovation Logistics warehouse construction ● Operation of Li-Flo, an integrated logistics system Started operation in September 2022 sequentially from the bases of the operating companies' Kawanishi ⇒ Introduction to the entire group is scheduled to be completed Reinforcement in To reinfo
Slide 32: New Businesses ① Strong sales of Thema-SAC
To foster new businessses New Businesses ① Strong sales of Thema-SAC® Expansion of the Burkmed business Thema-SAC® series of automated settlement machines for clinics Collaboration with retailers ●Installation results for the fiscal year ending June 2025: 255 units Cashless settlement support (YoY +
Slide 33: New Businesses ② Established OLSEED Co., Ltd.
(January 6, 2025) To foster new businessses New Businesses ② Established OLSEED Co., Ltd. Minimize environmental impact Olstech Corp. Started sales of OLSTECH ® low-thermal decomposition-type up-cycle unit OLSTECH| Three characteristics 1) Significant reductions in CO2 and dioxin emissions 2) Organi
Slide 34: New businesses ③ Babyeets launched
To foster new New businesses ③ "Babyeets®" launched businessses Newborn Live Distribution & Memorial Movie Creation Service "Babyeets®" Babyeets ® | Three Characteristics 01 Easy access to read-only cards 02 Real-time video viewing from remote areas 03 Provision of memorial video after hospitalizati
Slide 35: THAI OLBA Healthcare Business
To foster new businessses THAI OLBA Healthcare Business (from January 2023) ASEAN business development [Commemorative ceremony for the establishment of Bangkok on January 26, 2023] Main businesses of THAI OLBA Healthcare ➢ Sales of fully automated tablet packaging machines Concluded an official sale
Slide 36: ESG Initiatives
ESG Initiatives Sustainability Governance Social Environment (Governance) (Social) (environmental) ・Ensure management transparency, efficiency, and soundness. Enhancement of Group Value ・Sales of OLSTECH ® low-thermal ・Promote fair competition and business decomposition-type up-cycle unit [Human Cap
Slide 37: Efforts to Improve the Internal Environment
Efforts to Improve the Internal Environment Sustainability Promotion of diversity ➢ Active participation by women ➢ Encouraging men to take childcare leave ・2030 in the Annual Securities Report for the Fiscal Year Ended ・Through maternity leave guidebooks and e-Learning June 2025 Developing an envir
Slide 38: Human Resources Development as a Source of Growth
Human Resources Development as a Source of Growth Sustainability Building expertise and ◼ Systematic human resource development and acquisition of expertise management capabilities OLBA Academy, a 30-year-old internal training system Gradual expansion of e-Learning courses We provide opportunities f
Slide 39: Our strengths and utilization and weaknesses and countermeasures
Our strengths and utilization and weaknesses and countermeasures Strengths and Utilization ➢ No.1 of shares in Chugoku-Shikoku region (based on trust from customers and suppliers) ⇒ New investments can be implemented by securing stable profits ➢ To invest in human resource development and DX, which
Slide 40: SPD business
SPD business HOSNET・Japan, Inc. ● Acquisition of new customers and improvement of revenue ・Opening centers in Shikoku and expanding existing centers ・Develop customers in the Chugoku-Shikoku area ・Proposals for hospital management support, such as purchasing price reductions and insurance claim leak
Slide 41: Nursing Care Products Business
Nursing Care Products Business Life Care Co., Ltd. ● In-house construction of residential ● Increase market share in existing areas remodeling for nursing care ・Strengthen customer service by enhancing follow-up system ・Cultivating new users ・Promote sales activities using ICT ・Providing Safety and
Slide 42: Reference Materials
Reference Materials oo OLBA HEALTHCARE
Slide 43: Corporate Profile
Corporate Profile Trade name Olbas Healthcare Holding Inc (Former name: Kawanishi Holdings Co., Ltd.) Head Office 1-3, Shimo-Ishii 1-chome, Kita-ku, Okayama Founded in May 1921 Kawanishi Berkmed Corp. Established October 1967. Kawanishi Corporation Representative Director and President Yohei Maeshim
Slide 44: History
History May, 1921 Established Kawanishi Kikai Kikai Store in Ounji-cho, Okayama City (currently Chuo-cho, Kita-ku, Okayama City). Sep. 1927 Associated company Kawanishi Machinery Shop reorganized and established. Jun 1950 Reorganized and established Kawanishi Kikiten Co., Ltd. 1967 Oct Reorganized a
Slide 45: OLBA Employee Charter
OLBA Employee Charter Business Structure ○ Contribute to the development of medicine, medical care, and nursing care through business and contribute to the health and longevity of the national ○ Promptly and appropriately provide patients and medical providers with the benefits of innovative new fea
Slide 46: Consolidated Balance Sheets (Fiscal 2025)
Consolidated Balance Sheets (Fiscal 2025) Millions of yen Assets Amount Change Liabilities and Net Assets Amount Change Cash and deposits 3,470 738 Trade payables 27,043 843 Trade receivables 26,369 256 Short-term borrowings 400 △199 Commodities 6,417 473 Other 2,378 △538 Other 667 △130 Total curren
Slide 47: Consolidated Statements of Cash Flows (Fiscal 2025)
Consolidated Statements of Cash Flows (Fiscal 2025) Millions of yen FY June 2024 FY June 2025 Income before income taxes 2,243 1,919 Depreciation and amortization 557 628 Impairment loss - 26 Decrease (increase) in notes and accounts receivable- △1,593 △256 trade (increase in △) Decrease (increase)
Slide 48: Consolidated Statements of Cash Flows (Fiscal 2025)
Consolidated Statements of Cash Flows (Fiscal 2025) Millions of yen FY June 2024 FY June 2025 Net increase (decrease) in short-term borrowings (△) △300 △600 Proceeds from long-term debt - 2,000 Repayments of lease obligations △164 △156 Purchase of treasury stock △221 △135 Proceeds from sales of trea
Slide 49: Consolidated Financial Data ①
Consolidated Financial Data ① Item Unit 2021/6 2022/6 2023/6 2024/6 2025/6 Net sales Millions of yen 102,072 107,959 110,472 118,564 122,702 Operating income Millions of yen 1,540 2,073 2,151 2,226 1,979 Ordinary income Millions of yen 1,542 2,119 2,158 2,244 1,962 Profit attributable to owners of p
Slide 50: Consolidated Financial Data ②
Consolidated Financial Data ② Item Unit 2021/6 2022/6 2023/6 2024/6 2025/6 Sales CF Millions of yen 3,126 2,420 △659 2,084 1,626 Investment CF Millions of yen △630 △211 △306 △673 △1,635 Finance CF Millions of yen △2,262 △1,169 175 △1,089 686 Cash and cash equivalents Millions of yen 2,110 3,149 2,35
Slide 51: Summary of FY2025
Summary of FY2025 ※New highs for net sales Net sales ROE Dividend yield 122.7 billion yen 12.1% 4.0% (+3.5% YoY) (5-year average of 14.2%) (*As of June 30, 2025) Operating income PBR DOE Dividends on Equity 1.97 billion yen 0.97 times 4.0% (△11.1% YoY) (*As of June 30, 2025) (*As of June 30, 2025) 5
Slide 52: CSR Initiatives Contributing to Social Rooted in Local Communities
CSR Initiatives Contributing to Social Rooted in Local Communities Working together with local residents to create a future conducive to regional development and revitalization Faziano Okayama Okayama TEC PLANTER Club sponsor Partner companies Established in 2006 as Okayama Prefecture's first profes
Slide 53: Nippon Medical Manufacturing Commons MINC Association
Nippon Medical Manufacturing Commons MINC Association "Study Group on the Latest Trends in Overseas Medical Devices" On Medical Globe Sharing and discussing information on the latest overseas medical device information among various industries Doctors, manufacturers, the Ministry of Economy, Trade a
Slide 54: Corporate Information/Inquiries
Corporate Information/Inquiries [Fiscal year] From July 1 to June 30 of the following year [Ordinary General Meeting of Shareholders] Held annually in September [Stock Exchange Lists] Tokyo Stock Exchange (Standard Market) Securities code: 2689 [Number of shares per unit] 100 shares [Contact] OLBA H
Slide 55: Disclaimer
・Although the datum provided in this document is intended to be used with all possible care, the accuracy and completeness of such information is not guaranteed. ・Opinions and forecasts contained in the data are our forecasts based on information available at the time of preparation of the materials
Olba Healthcare Holdings — FY2025 Earnings Presentation on 6ix